Home > Insider Trading > Filing (0001225208-16-037553)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
310158	Merck & Co. Inc.	MRK	Pharmaceutical Preparations (2834)	221918501

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1181175	C Kenneth Frazier	Merck &Amp; Co., Inc. 2000 Galloping Hill Road Kenilworth NJ 07033	Chairman, President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2016-08-05	252,000	$44.30	760,877	No	4	M	Direct
Common Stock	Acquisiton	2016-08-05	140,000	$23.45	900,877	No	4	M	Direct
Common Stock	Disposition	2016-08-05	19,048	$62.08	881,829	No	4	S	Direct
Common Stock	Disposition	2016-08-05	140,000	$62.24	741,829	No	4	S	Direct
Common Stock	Disposition	2016-08-05	232,952	$61.54	508,877	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2016-08-05	252,000	$0.00	252,000	$44.30
Common Stock	Stock Option (right to buy)	Disposition	2016-08-05	140,000	$0.00	140,000	$23.45

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2009-02-28	2018-02-28	No	4	M	Direct
140,000	2010-04-24	2019-04-23	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock - 401(K) Plan	3,726	Indirect	By 401(k)

Footnotes

The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.0100 to $62.3800, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.3000 to $61.9200, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.
Holdings include shares acquired in dividend reinvestment transactions.
Includes shares acquired and dividends earned through July 8, 2016, in the Merck U.S. Savings Plan, a 401(k) plan.
The option became exercisable in equal installments on 2/28/2009, 2/28/2010 and 2/28/2011.
The option became exercisable in equal installments on 4/24/2010, 4/24/2011 and 4/24/2012.